Velocity Development

G. Paul Evans Named President and CEO

Durham, N.C. -- February 5, 2019 – Velocity Clinical Research, a clinical trials site organization focused on setting a new bar for providing rapid data delivery with the highest level of patient care, has announced it has acquired its first three research sites in the USA.  The company acquired Clinical Research Institute of Southern Oregon (CRISOR) of Medford, Oregon and New Horizons Clinical Research (NHCR) of Cincinnati, Ohio in an earlier single transaction.  In December 2018 the company also acquired MD Clinical of Hallandale Beach, Florida.  Velocity investigator sites have 20+ years of clinical trial experience and over 1700 completed studies across a broad range of therapeutic areas.

the same time the company announced that Dr. G. Paul Evans has been named
President and Chief Executive Officer. Paul joins the company after 26 years of
“perfect symmetry” in the site business: 13 years running sites and 13 years
managing them from the sponsor/CRO side. He has served as Corporate VP, Global
Site Solutions at PAREXEL; Vice President, Global Site Management at IQVIA; and
was a founder and Managing Director of Synexus, a gl...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee